Cite
MLA Citation
S.D. Smith et al.. “RAPID AND DURABLE RESPONSES WITH THE SYK/JAK INHIBITOR CERDULATINIB IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA—ALONE OR IN COMBINATION WITH RITUXIMAB.” Hematological oncology, vol. 37, n.d., pp. 61–62. http://access.bl.uk/ark:/81055/vdc_100086209777.0x000035